William John Scheessele

Insider Reports History

Entity
Individual
Location
620 Wade Avenue, Unit 501, Raleigh, NC
Signature
/s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William John Scheessele:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Humacyte, Inc. Chief Commercial Officer Stock Options (right to buy) 283K Jan 21, 2025 Direct

Insider Reports Filed by William John Scheessele

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HUMA Humacyte, Inc. Jan 21, 2025 1 $0 4 Jan 23, 2025 Chief Commercial Officer
HUMA Humacyte, Inc. Dec 8, 2023 1 $0 4 Dec 12, 2023 Chief Commercial Officer
HUMA Humacyte, Inc. Dec 13, 2022 1 $15.5K 4 Dec 15, 2022 Chief Commercial Officer
HUMA Humacyte, Inc. Dec 8, 2022 1 $0 4 Dec 12, 2022 Chief Commercial Officer
HUMA Humacyte, Inc. May 24, 2022 1 $49.7K 4 May 25, 2022 Chief Commercial Officer
HUMA Humacyte, Inc. Oct 13, 2021 1 $0 4 Oct 15, 2021 Chief Commercial Officer
HUMA Humacyte, Inc. Aug 26, 2021 0 $0 3 Aug 27, 2021 Chief Commercial Officer